Longduoduo Co Ltd

Longduoduo Company Limited

Company overview

• Longduoduo is a Nevada holding company that operates through seven PRC-based subsidiaries. The holding company does not conduct operational activities directly; operations are carried out by PRC subsidiaries owned via intermediary entities in Hong Kong and the British Virgin Islands.
• Operating subsidiaries (as of June 30, 2026):
  • Longduoduo Health Technology Co., Ltd. (Inner Mongolia)
  • Qingguo Health Consulting Co., Ltd. (Inner Mongolia)
  • Rongbin Health Consulting Co., Ltd. (Inner Mongolia)
  • Chengheng Health Consulting Co., Ltd. (Inner Mongolia)
  • Tianju Health Consulting Co., Ltd. (Inner Mongolia)
  • Julong Health Consulting Co., Ltd. (Beijing)
  • Yihua Health Consulting Co., Ltd. (Beijing)
• Longduoduo HK was part of the structure but was deregistered on August 28, 2026.

Business model

• Core activity: Health management services and preventive healthcare delivered primarily through a sales agency model.
• Principal partner: Inner Mongolia Honghai Health Management Co., Ltd. (“Honghai”). The subsidiaries act as sales agents for Honghai and receive commissions on services Honghai provides.
• Revenue mix:
  • Commissions from Honghai accounted for more than 99.6% of gross revenue for the year ended June 30, 2026.
  • The group previously engaged in principal sales (buying and reselling services). Principal sales revenue declined sharply in 2026 (approximately a 95% decrease from 2025). The company plans to focus on agency (commission-based) sales going forward.
• Agency agreements with Honghai expire in June 2029.

Services offered

• Meridian-regulating and Consciousness-restoring iatrotechnics (traditional Chinese medicine)
• Double Blood Purification (blood filtration)
• Immunological Ozonated Autohemotherapy (ozone-based treatment)
• PRP (platelet-rich plasma) therapy for joint-related conditions
• Services are provided by licensed medical institutions. Honghai is responsible for service development and provision; the subsidiaries handle promotion, sales and commission collection. Honghai bears liability for service quality and customer liabilities.

Customers and market focus

• Geographic focus: Inner Mongolia, with related entities in Beijing.
• Clinical focus: Preventive cardiovascular and cerebrovascular health and related conditions, including myocardial infarction, cerebral infarction and digestive issues.
• Primary revenue driver: Commissions from Honghai.

Growth plan

• Short- to medium-term objectives:
  • Expand product offerings.
  • Expand nationwide coverage via a network of medical centers.
  • Upgrade service standards and customer experience.
• Funding approach: Continue outside financing to support expansion while maintaining the relationship with Honghai as the primary revenue source through 2029.

Corporate structure and roles

• Nevada holding company with operations conducted through PRC subsidiaries and intermediary holding entities in Hong Kong and the British Virgin Islands.
• Principal PRC subsidiaries and key activities:
  • Longduoduo Health Technology Co., Ltd. — health information consulting; corporate and health-management consulting
  • Qingguo Health Consulting Co., Ltd. — health management consulting; medical information consulting; sales of food
  • Rongbin Health Consulting Co., Ltd. — medical information consulting; corporate management consulting; health management consulting
  • Chengheng Health Consulting Co., Ltd. — medical information consulting; corporate management consulting; health management consulting
  • Tianju Health Consulting Co., Ltd. — sales of Class I medical equipment, pre-packaged foods, hygiene products, cosmetics; consulting and technology services
  • Julong Health Consulting Co., Ltd. (Beijing) — health management consulting
  • Yihua Health Consulting Co., Ltd. (Beijing) — health management consulting
• Offices and addresses are located in Inner Mongolia and Beijing.

Employees and facilities

• Total full-time employees: 51
  • Longduoduo Health Technology: 16
  • Rongbin: 12
  • Qingguo: 9
  • Chengheng: 8
  • Tianju: 6
• Office lease highlights (amounts shown in USD unless noted):
  • Tianju: approx. $19,000 annually (RMB 137,000), 4/1/2024–3/31/2027
  • Qingguo: initial lease $30,700 (RMB 220,000) for 9/10/2024–9/10/2025; direct lease with landlord from 9/10/2025; renewal on 9/18/2026 for about $30,898 per year
  • Chengheng: $16,700 (RMB 120,000) for 11/20/2024–11/20/2025; additional lease $24,000 (RMB 170,000) for 8/8/2025–8/7/2028
  • Longduoduo Health Technology: $4,200 (RMB 30,000) for 3/11/2025–3/10/2026; renewal on 3/11/2026 at about $3,621 (RMB 25,000) per year
  • Rongbin: $1,685 (RMB 12,000) for 7/20/2025–7/19/2026 (renewed for 2026–2027); additional lease $14,000 (RMB 100,320) for 9/1/2025–8/31/2026 (renewed for 2026–2027)
• Some leases are subleases and others are direct agreements with property owners; several lease terms extend through 2027–2028.

Tax and selected financial items

• Applicable tax rates:
  • United States (Longduoduo): 21% federal rate
  • Hong Kong: 16.5% profits tax for Hong Kong entities (Longduoduo HK and LDDJK)
  • PRC: 25% standard enterprise income tax for Julong and its subsidiaries
• PRC income tax accruals (year ended):
  • 2026: $66,451 (of which $62,690 related to the transfer of Longduoduo Health Technology to Julong, recorded by Longduoduo HK)
  • 2025: $222,268
• Distributions: No PRC subsidiary has paid dividends or distributions to Longduoduo or its subsidiaries as of the date of the report.
• Revenue concentration: Commissions from Honghai represented 99.6% of gross revenue in 2026; principal sales revenue declined sharply in 2026 versus 2025.

Licenses and regulatory notes

• Each PRC subsidiary holds operating licenses for activities such as health management consulting, medical information consulting, and sales of food and medical products.
• The company is subject to evolving PRC regulatory requirements affecting foreign-listed entities, data privacy and cross-border activities. Listing plans (OTCQB or Nasdaq) are subject to CSRC approvals and applicable regulatory developments.

Summary

Longduoduo Company Limited is a Nevada holding company that provides preventive healthcare and health-management services through seven PRC subsidiaries. The business primarily operates as a sales agent for Inner Mongolia Honghai Health Management Co., Ltd., with Honghai commissions accounting for the vast majority of 2026 revenue. The company has shifted away from principal sales toward agency-based revenue, plans to expand its product and geographic reach, maintains a 51-person workforce in the PRC, and operates multiple leased offices in Inner Mongolia and Beijing. Agency agreements with Honghai remain a primary revenue source through June 2029.